GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Institutional Ownership

SynCore Biotechnology Co (ROCO:4192) Institutional Ownership : 0.04% (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SynCore Biotechnology Co's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SynCore Biotechnology Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SynCore Biotechnology Co's Float Percentage Of Total Shares Outstanding is 0.00%.


SynCore Biotechnology Co Institutional Ownership Historical Data

The historical data trend for SynCore Biotechnology Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Institutional Ownership Chart

SynCore Biotechnology Co Historical Data

The historical data trend for SynCore Biotechnology Co can be seen below:

2014-10-31 2014-11-30
Institutional Ownership 0.08 0.04

SynCore Biotechnology Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines